Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1971 Apr;68(4):770–772. doi: 10.1073/pnas.68.4.770

ε-(γ-Glutamyl)lysine in Fibrin: Lack of Crosslink Formation in Factor XIII Deficiency

J J Pisano *, J S Finlayson *, Marjorie P Peyton *, Yumiko Nagai *
PMCID: PMC389039  PMID: 5279517

Abstract

Fibrin clots formed in normal plasma contained about 6 mol of ε-(γ-glutamyl)lysine per mol of fibrin, whereas those formed in plasma from individuals with Factor XIII deficiency contained little or none of this crosslink (0.02-0.64 mol/mol of fibrin). Partial supplementation of the plasma with Factor XIII, at a single concentration tested, commensurately increased the number of crosslinks.

Full text

PDF
770

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alami S. Y., Hampton J. W., Race G. J., Speer R. J. Fibrin stabilizing factor factor 8). Am J Med. 1968 Jan;44(1):1–7. doi: 10.1016/0002-9343(68)90231-3. [DOI] [PubMed] [Google Scholar]
  2. Benson J. V., Jr, Jones R. T., Cormick J., Patterson J. A. Accelerated automatic chromatographic analysis of peptides on a spherical resin. Anal Biochem. 1966 Jul;16(1):91–106. doi: 10.1016/0003-2697(66)90084-4. [DOI] [PubMed] [Google Scholar]
  3. Britten A. F. Congenital deficiency of factor 13 (fibrin-stabilizing factor): Report of a case and review of the literature. Am J Med. 1967 Nov;43(5):751–761. doi: 10.1016/0002-9343(67)90117-9. [DOI] [PubMed] [Google Scholar]
  4. Chen R., Doolittle R. F. Isolation, characterization, and location of a donor-acceptor unit from cross-linked fibrin. Proc Natl Acad Sci U S A. 1970 Jun;66(2):472–479. doi: 10.1073/pnas.66.2.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DAVIS N. C., SMITH E. L. Purification and some properties of prolidase of swine kidney. J Biol Chem. 1957 Jan;224(1):261–275. [PubMed] [Google Scholar]
  6. DUCKERT F., JUNG E., SHMERLING D. H. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1960 Dec 15;5:179–186. [PubMed] [Google Scholar]
  7. Egbring R., Andrassy K., Egli H., Meyer-Lindenberg J. Untersuchungen bei zwei Patienten mit kongenitalem Faktor-XII-Mangel. (Zugleich ein Beitrag zur Problematik der Bestimmung des Faktors XIII) Thromb Diath Haemorrh. 1970 May 31;23(2):313–339. [PubMed] [Google Scholar]
  8. Hubbard R. W. Studies in accelerated amino acid analysis. Biochem Biophys Res Commun. 1965 Jun 9;19(6):679–685. doi: 10.1016/0006-291x(65)90310-4. [DOI] [PubMed] [Google Scholar]
  9. LOEWY A. G., DUNATHAN K., KRIEL R., WOLFINGER H. L., Jr Fibrinase. I. Purification of substrate and enzyme. J Biol Chem. 1961 Oct;236:2625–2633. [PubMed] [Google Scholar]
  10. Laki K., Lóránd L. On the Solubility of Fibrin Clots. Science. 1948 Sep 10;108(2802):280–280. doi: 10.1126/science.108.2802.280. [DOI] [PubMed] [Google Scholar]
  11. Lorand L., Downey J., Gotoh T., Jacobsen A., Tokura S. The transpeptidase system which crosslinks fibrin by gamma-glutamyle-episilon-lysine bonds. Biochem Biophys Res Commun. 1968 Apr 19;31(2):222–230. doi: 10.1016/0006-291x(68)90734-1. [DOI] [PubMed] [Google Scholar]
  12. Lorand L., Urayama T., Atencio A. C., Hsia D. Y. Inheritance of deficiency of fibrin-stabilizing factor (factor 13). Am J Hum Genet. 1970 Jan;22(1):89–95. [PMC free article] [PubMed] [Google Scholar]
  13. MOSESSON M. W. The preparation of human fibrinogen free of plasminogen. Biochim Biophys Acta. 1962 Feb 26;57:204–213. doi: 10.1016/0006-3002(62)91112-5. [DOI] [PubMed] [Google Scholar]
  14. Matacić S., Loewy A. G. The identification of isopeptide crosslinks in insoluble fibrin. Biochem Biophys Res Commun. 1968 Feb 26;30(4):356–362. doi: 10.1016/0006-291x(68)90750-x. [DOI] [PubMed] [Google Scholar]
  15. McKee P. A., Mattock P., Hill R. L. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc Natl Acad Sci U S A. 1970 Jul;66(3):738–744. doi: 10.1073/pnas.66.3.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miloszewski K., Walls W. D., Losowsky M. S. Absence of plasma transamidase activity in congenital deficiency of fibrin stabilizing factor (Factor 13). Br J Haematol. 1969 Aug;17(2):159–162. doi: 10.1111/j.1365-2141.1969.tb01354.x. [DOI] [PubMed] [Google Scholar]
  17. Pisano J. J., Finlayson J. S., Peyton M. P. Chemical and enzymic detection of protein cross-links. Measurement of epsilon-(gamma-glutamyl)lysine in fibrin polymerized by factor XIII. Biochemistry. 1969 Mar;8(3):871–876. doi: 10.1021/bi00831a016. [DOI] [PubMed] [Google Scholar]
  18. Pisano J. J., Finlayson J. S., Peyton M. P. [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine]. Science. 1968 May 24;160(3830):892–893. doi: 10.1126/science.160.3830.892. [DOI] [PubMed] [Google Scholar]
  19. Steinberg A. G., Ratnoff O. D. Inheritance of factor XIII. Am J Hum Genet. 1970 Sep;22(5):597–598. [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES